Adjuvant or radical fractionated stereotactic radiotherapy for patients with pituitary functional and nonfunctional macroadenoma

Radiation Oncology

Volumn 6, Issue 1, 2011, Pages

  Weber, Damien C ^a   Momjian, Shahan ^a   Pralong, François P ^b   Meyer, Patrick ^a   Villemure, Jean G ^c   Pica, Alessia ^b,d  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACTH SECRETING ADENOMA; ADULT; AGED; ARTICLE; ASTHENIA; CANCER REGRESSION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CRANIOTOMY; FEMALE; FOLLOW UP; GROWTH HORMONE SECRETING ADENOMA; HEADACHE; HUMAN; HYPOPHYSIS ADENOMA; HYPOPITUITARISM; MALE; NAUSEA; OPTIC CHIASM; PROLACTINOMA; RADIATION DOSE FRACTIONATION; RADIATION HAZARD; RADIATION SAFETY; SALVAGE THERAPY; STEREOTACTIC BODY RADIATION THERAPY; TRANSSPHENOIDAL SURGERY; TUMOR GROWTH; TUMOR VOLUME; VISUAL FIELD DEFECT; ADENOMA; HYPOPHYSIS TUMOR; MIDDLE AGED; RADIOSURGERY; RETROSPECTIVE STUDY;

ADENOMA; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; RADIOSURGERY; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 82955188777     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-6-169     Document Type: Article

References (44)

1. Elhateer H, Muanza T, Roberge D, Ruo R, Eldebawy E, Lambert C, et al. Fractionated stereotactic radiotherapy in the treatment of pituitary macroadenomas. Curr Oncol 2008, 15(6):286-92. 2601024, 19079630.
2. Scheithauer BW, Kovacs KT, Laws ER, Randall RV. Pathology of invasive pituitary tumors with special reference to functional classification. J Neurosurg 1986, 65(6):733-44. 10.3171/jns.1986.65.6.0733, 3095506.
3. Buchfelder M, Fahlbusch R, Adams EF, Kiesewetter F, Thierauf P. Proliferation parameters for pituitary adenomas. Acta Neurochir Suppl 1996, 65:18-21.
4. Hardy J, Vezina JL. Transsphenoidal neurosurgery of intracranial neoplasm. Adv Neurol 1976, 15:261-73.
5. Bohinski RJ, Warnick RE, Gaskill-Shipley MF, Zuccarello M, van Loveren HR, Kormos DW, et al. Intraoperative magnetic resonance imaging to determine the extent of resection of pituitary macroadenomas during transsphenoidal microsurgery. Neurosurgery 2001, 49(5):1133-43. discussion 1143-4.
6. Knosp E, Perneczky A, Kitz K, Grunert P, Wild A. The need for adjunctive focused radiation therapy in pituitary adenomas. Acta Neurochir Suppl 1995, 63:81-4.
7. Park P, Chandler WF, Barkan AL, Orrego JJ, Cowan JA, Griffith KA, et al. The role of radiation therapy after surgical resection of nonfunctional pituitary macroadenomas. Neurosurgery 2004, 55(1):100-6. discussion 106-7, 10.1227/01.NEU.0000126885.71242.D7, 15214978.
8. Kovalic JJ, Grigsby PW, Fineberg BB. Recurrent pituitary adenomas after surgical resection: the role of radiation therapy. Radiology 1990, 177(1):273-5.
9. McCollough WM, Marcus RB, Rhoton AL, Ballinger WE, Million RR. Long-term follow-up of radiotherapy for pituitary adenoma: the absence of late recurrence after greater than or equal to 4500 cGy. Int J Radiat Oncol Biol Phys 1991, 21(3):607-14. 10.1016/0360-3016(91)90677-V, 1907958.
10. Zierhut D, Flentje M, Adolph J, Erdmann J, Raue F, Wannenmacher M. External radiotherapy of pituitary adenomas. Int J Radiat Oncol Biol Phys 1995, 33(2):307-14. 10.1016/0360-3016(95)00071-6, 7673017.
11. Zaugg M, Adaman O, Pescia R, Landolt AM. External irradiation of macroinvasive pituitary adenomas with telecobalt: a retrospective study with long-term follow-up in patients irradiated with doses mostly of between 40-45 Gy. Int J Radiat Oncol Biol Phys 1995, 32(3):671-80. 10.1016/0360-3016(94)00620-Z, 7790253.
12. Tsang RW, Brierley JD, Panzarella T, Gospodarowicz MK, Sutcliffe SB, Simpson WJ. Radiation therapy for pituitary adenoma: treatment outcome and prognostic factors. Int J Radiat Oncol Biol Phys 1994, 30(3):557-65.
13. Mackley HB, Reddy CA, Lee SY, Harnisch GA, Mayberg MR, Hamrahian AH, et al. Intensity-modulated radiotherapy for pituitary adenomas: the preliminary report of the Cleveland Clinic experience. Int J Radiat Oncol Biol Phys 2007, 67(1):232-9. 10.1016/j.ijrobp.2006.08.039, 17084541.
14. Ronson BB, Schulte RW, Han KP, Loredo LN, Slater JM, Slater JD. Fractionated proton beam irradiation of pituitary adenomas. Int J Radiat Oncol Biol Phys 2006, 64(2):425-34. 10.1016/j.ijrobp.2005.07.978, 16257131.
15. Kim M, Paeng S, Pyo S, Jeong Y, Lee S, Jung Y. Gamma Knife surgery for invasive pituitary macroadenoma. J Neurosurg 2006, 105 Suppl:26-30.
16. Pollock BE, Cochran J, Natt N, Brown PD, Erickson D, Link MJ, et al. Gamma knife radiosurgery for patients with nonfunctioning pituitary adenomas: results from a 15-year experience. Int J Radiat Oncol Biol Phys 2008, 70(5):1325-9. 10.1016/j.ijrobp.2007.08.018, 18029107.
17. Jagannathan J, Yen CP, Pouratian N, Laws ER, Sheehan JP. Stereotactic radiosurgery for pituitary adenomas: a comprehensive review of indications, techniques and long-term results using the Gamma Knife. J Neurooncol 2009, 92(3):345-56. 10.1007/s11060-009-9832-5, 19357961.
18. Paek SH, Downes MB, Bednarz G, Keane WM, Werner-Wasik M, Curran WJ, et al. Integration of surgery with fractionated stereotactic radiotherapy for treatment of nonfunctioning pituitary macroadenomas. Int J Radiat Oncol Biol Phys 2005, 61(3):795-808. 10.1016/j.ijrobp.2004.07.688, 15708259.
19. Colin P, Jovenin N, Delemer B, Caron J, Grulet H, Hecart AC, et al. Treatment of pituitary adenomas by fractionated stereotactic radiotherapy: a prospective study of 110 patients. Int J Radiat Oncol Biol Phys 2005, 62(2):333-41. 10.1016/j.ijrobp.2004.09.058, 15890572.
20. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000, 92(3):205-16. 10.1093/jnci/92.3.205, 10655437.
21. Kaplan E, Meier P. Nonparametric estimation for incomplete observations. J Am Stat Assoc 1958, 53:458-481.
22. Mitsumori M, Shrieve DC, Alexander E, Kaiser UB, Richardson GE, Black PM, et al. Initial clinical results of LINAC-based stereotactic radiosurgery and stereotactic radiotherapy for pituitary adenomas. Int J Radiat Oncol Biol Phys 1998, 42(3):573-80. 10.1016/S0360-3016(98)00256-9, 9806517.
23. Milker-Zabel S, Debus J, Thilmann C, Schlegel W, Wannenmacher M. Fractionated stereotactically guided radiotherapy and radiosurgery in the treatment of functional and nonfunctional adenomas of the pituitary gland. Int J Radiat Oncol Biol Phys 2001, 50(5):1279-86. 10.1016/S0360-3016(01)01535-8, 11483339.
24. Schalin-Jantti C, Valanne L, Tenhunen M, Setala K, Paetau A, Sane T, et al. Outcome of fractionated stereotactic radiotherapy in patients with pituitary adenomas resistant to conventional treatments: a 5.25-year follow-up study. Clin Endocrinol (Oxf) 2010, 73(1):72-7.
25. Mingione V, Yen CP, Vance ML, Steiner M, Sheehan J, Laws ER, et al. Gamma surgery in the treatment of nonsecretory pituitary macroadenoma. J Neurosurg 2006, 104(6):876-83. 10.3171/jns.2006.104.6.876, 16776330.
26. Leber KA, Bergloff J, Pendl G. Dose-response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg 1998, 88(1):43-50. 10.3171/jns.1998.88.1.0043, 9420071.
27. Jagannathan J, Sheehan JP, Pouratian N, Laws ER, Steiner L, Vance ML. Gamma Knife surgery for Cushing's disease. J Neurosurg 2007, 106(6):980-7. 10.3171/jns.2007.106.6.980, 17564168.
28. Sheehan JP, Jagannathan J, Pouratian N, Steiner L. Stereotactic radiosurgery for pituitary adenomas: a review of the literature and our experience. Front Horm Res 2006, 34:185-205.
29. Pollock BE, Kondziolka D, Lunsford LD, Flickinger JC. Stereotactic radiosurgery for pituitary adenomas: imaging, visual and endocrine results. Acta Neurochir Suppl 1994, 62:33-8.
30. Jane JA, Vance ML, Woodburn CJ, Laws ER. Stereotactic radiosurgery for hypersecreting pituitary tumors: part of a multimodality approach. Neurosurg Focus 2003, 14(5):e12.
31. Parsons JT, Bova FJ, Fitzgerald CR, Mendenhall WM, Million RR. Radiation optic neuropathy after megavoltage external-beam irradiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys 1994, 30(4):755-63.
32. van den Bergh AC, Hoving MA, Links TP, Dullaart RP, Ranchor AV, ter Weeme CA, et al. Radiation optic neuropathy after external beam radiation therapy for acromegaly: report of two cases. Radiother Oncol 2003, 68(2):101-3. 10.1016/S0167-8140(03)00201-9, 12972303.
33. Aristizabal S, Caldwell WL, Avila J. The relationship of time-dose fractionation factors to complications in the treatment of pituitary tumors by irradiation. Int J Radiat Oncol Biol Phys 1977, 2(7-8):667-73. 10.1016/0360-3016(77)90046-3, 197051.
34. McClelland S, Higgins PD, Gerbi BJ, Orner JB, Hall WA. Fractionated stereotactic radiotherapy for pituitary adenomas following microsurgical resection: safety and efficacy. Technol Cancer Res Treat 2007, 6(3):177-80.
35. Selch MT, Gorgulho A, Lee SP, Mattozo C, Solberg TD, Agazaryan N, et al. Stereotactic radiotherapy for the treatment of pituitary adenomas. Minim Invasive Neurosurg 2006, 49(3):150-5. 10.1055/s-2006-944240, 16921455.
36. Roug S, Rasmussen AK, Juhler M, Kosteljanetz M, Poulsgaard L, Heeboll H, et al. Fractionated stereotactic radiotherapy in patients with acromegaly: an interim single-centre audit. Eur J Endocrinol 2010, 162(4):685-94. 10.1530/EJE-09-1045, 20133445.
37. Minniti G, Traish D, Ashley S, Gonsalves A, Brada M. Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas. Clin Endocrinol (Oxf) 2006, 64(5):542-8.
38. Kong DS, Lee JI, Lim do H, Kim KW, Shin HJ, Nam DH, et al. The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas: long-term results of 125 consecutive patients treated in a single institution. Cancer 2007, 110(4):854-60. 10.1002/cncr.22860, 17599761.
39. Brada M, Ford D, Ashley S, Bliss JM, Crowley S, Mason M, et al. Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. BMJ 1992, 304(6838):1343-6. 10.1136/bmj.304.6838.1343, 1882057, 1611331.
40. Breen P, Flickinger JC, Kondziolka D, Martinez AJ. Radiotherapy for nonfunctional pituitary adenoma: analysis of long-term tumor control. J Neurosurg 1998, 89(6):933-8. 10.3171/jns.1998.89.6.0933, 9833818.
41. Guinan EM, Lowy C, Stanhope N, Lewis PD, Kopelman MD. Cognitive effects of pituitary tumours and their treatments: two case studies and an investigation of 90 patients. J Neurol Neurosurg Psychiatry 1998, 65(6):870-6. 10.1136/jnnp.65.6.870, 2170410, 9854963.
42. Brummelman P, Elderson MF, Dullaart RP, van den Bergh AC, Timmer CA, van den Berg G, et al. Cognitive functioning in patients treated for nonfunctioning pituitary macroadenoma and the effects of pituitary radiotherapy. Clin Endocrinol (Oxf) 2011, 74(4):481-7.
43. Tiemensma J, Kokshoorn NE, Biermasz NR, Keijser BJ, Wassenaar MJ, Middelkoop HA, et al. Subtle cognitive impairments in patients with long-term cure of Cushing's disease. J Clin Endocrinol Metab 2010, 95(6):2699-714. 10.1210/jc.2009-2032, 20371667.
44. McCord MW, Buatti JM, Fennell EM, Mendenhall WM, Marcus RB, Rhoton AL, et al. Radiotherapy for pituitary adenoma: long-term outcome and sequelae. Int J Radiat Oncol Biol Phys 1997, 39(2):437-44. 10.1016/S0360-3016(97)00335-0, 9308948.